PRTK - Paratek Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue29-4,342
Cost of Revenue---
Gross Profit29-4,342
Operating Expenses
Research Development83,46050,7655,014
Selling General and Administrative26,05516,4285,848
Non Recurring-2,8601,278
Total Operating Expenses---
Operating Income or Loss-109,486-70,053-7,798
Income from Continuing Operations
Total Other Income/Expenses Net1,073-37-9,319
Earnings Before Interest and Taxes-108,413-70,090-17,117
Interest Expense3,223770718
Income Before Tax-111,636-70,860-17,835
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-111,636-70,860-17,835
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-111,636-70,860-17,835
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-111,636-70,860-19,762